Cargando…

Impact of changing diagnostic criteria on the diagnosis of serrated polyposis syndrome

Background and study aims  The World Health Organization criteria for serrated polyposis syndrome (SPS) were established in 2010 and modified in 2019. Neither set of criteria have been validated against genetic markers or proven to be the optimal criteria for defining colorectal cancer risk in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: McWhinney, Connor D., Lahr, Rachel E., Lee, Christopher J., El-Rahyel, Ahmed, Rex, Douglas K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812648/
https://www.ncbi.nlm.nih.gov/pubmed/36618871
http://dx.doi.org/10.1055/a-1958-2529
_version_ 1784863774751064064
author McWhinney, Connor D.
Lahr, Rachel E.
Lee, Christopher J.
El-Rahyel, Ahmed
Rex, Douglas K.
author_facet McWhinney, Connor D.
Lahr, Rachel E.
Lee, Christopher J.
El-Rahyel, Ahmed
Rex, Douglas K.
author_sort McWhinney, Connor D.
collection PubMed
description Background and study aims  The World Health Organization criteria for serrated polyposis syndrome (SPS) were established in 2010 and modified in 2019. Neither set of criteria have been validated against genetic markers or proven to be the optimal criteria for defining colorectal cancer risk in patients with serrated colorectal lesions. In this study, we sought to gain insight into how frequently the change in SPS criteria in 2019 impacted the diagnosis of SPS. Patients and methods  We reviewed 279 patients with SPS diagnosed between 2010 and 2019 using the 2010 criteria (n = 163) or since 2019 using the 2019 criteria (n = 116). We reviewed whether patients in each group met the diagnosis of SPS by the alternative criteria. Results  Of those diagnosed using 2010 criteria, 5.5 % did not meet 2019 criteria. Of those diagnosed by 2019 criteria, 10.3 % did not meet 2010 criteria. Conclusions  Most patients with SPS in our database met the diagnosis of SPS by both 2010 and 2019 criteria, with only 5 % to 10 % of patients in each cohort not meeting the alternative diagnostic criteria.
format Online
Article
Text
id pubmed-9812648
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-98126482023-01-05 Impact of changing diagnostic criteria on the diagnosis of serrated polyposis syndrome McWhinney, Connor D. Lahr, Rachel E. Lee, Christopher J. El-Rahyel, Ahmed Rex, Douglas K. Endosc Int Open Background and study aims  The World Health Organization criteria for serrated polyposis syndrome (SPS) were established in 2010 and modified in 2019. Neither set of criteria have been validated against genetic markers or proven to be the optimal criteria for defining colorectal cancer risk in patients with serrated colorectal lesions. In this study, we sought to gain insight into how frequently the change in SPS criteria in 2019 impacted the diagnosis of SPS. Patients and methods  We reviewed 279 patients with SPS diagnosed between 2010 and 2019 using the 2010 criteria (n = 163) or since 2019 using the 2019 criteria (n = 116). We reviewed whether patients in each group met the diagnosis of SPS by the alternative criteria. Results  Of those diagnosed using 2010 criteria, 5.5 % did not meet 2019 criteria. Of those diagnosed by 2019 criteria, 10.3 % did not meet 2010 criteria. Conclusions  Most patients with SPS in our database met the diagnosis of SPS by both 2010 and 2019 criteria, with only 5 % to 10 % of patients in each cohort not meeting the alternative diagnostic criteria. Georg Thieme Verlag KG 2023-01-04 /pmc/articles/PMC9812648/ /pubmed/36618871 http://dx.doi.org/10.1055/a-1958-2529 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle McWhinney, Connor D.
Lahr, Rachel E.
Lee, Christopher J.
El-Rahyel, Ahmed
Rex, Douglas K.
Impact of changing diagnostic criteria on the diagnosis of serrated polyposis syndrome
title Impact of changing diagnostic criteria on the diagnosis of serrated polyposis syndrome
title_full Impact of changing diagnostic criteria on the diagnosis of serrated polyposis syndrome
title_fullStr Impact of changing diagnostic criteria on the diagnosis of serrated polyposis syndrome
title_full_unstemmed Impact of changing diagnostic criteria on the diagnosis of serrated polyposis syndrome
title_short Impact of changing diagnostic criteria on the diagnosis of serrated polyposis syndrome
title_sort impact of changing diagnostic criteria on the diagnosis of serrated polyposis syndrome
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812648/
https://www.ncbi.nlm.nih.gov/pubmed/36618871
http://dx.doi.org/10.1055/a-1958-2529
work_keys_str_mv AT mcwhinneyconnord impactofchangingdiagnosticcriteriaonthediagnosisofserratedpolyposissyndrome
AT lahrrachele impactofchangingdiagnosticcriteriaonthediagnosisofserratedpolyposissyndrome
AT leechristopherj impactofchangingdiagnosticcriteriaonthediagnosisofserratedpolyposissyndrome
AT elrahyelahmed impactofchangingdiagnosticcriteriaonthediagnosisofserratedpolyposissyndrome
AT rexdouglask impactofchangingdiagnosticcriteriaonthediagnosisofserratedpolyposissyndrome